Clinical Trials Browser

Advanced Pancreatic Cancer × ADI PEG20 × Clear all

NCT02101580 2020-10-01

Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer

Phase 1 Completed

Gastrointestinal

Advanced Pancreatic Cancer